Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series

Keyphrases

• Phage 100%
• Compassionate Use 100%
• Pseudomonas Aeruginosa Infection 100%
• Clinical Outcomes 25%
• Clinical Trials 25%
• Science Foundation 25%
• Israel 12%
• Israeli 12%
• United States 12%
• Clinical Data 12%
• Antibiotics 12%
• Topical Application 12%
• Twice Daily 12%
• Microbiology 12%
• Phage Therapy 12%
• White Blood Cell Count 12%
• Treatment Strategy 12%
• Traditional Treatment 12%
• Transient Reduction 12%
• Infection Site 12%
• Bi-national 12%
• Administration Regimen 12%
• Clinical Protocols 12%
• Device Infection 12%
• Non-resolving 12%
• Duration of Therapy 12%
• Osteoarticular 12%
• Family Support Program 12%
• Daily Regimen 12%
• Liver Function Enzymes 12%
• Data Administration 12%
• Refractory Infection 12%
• Clinical Failure 12%

Medicine and Dentistry

• Compassionate Use 100%
• Pseudomonas Infection 100%
• Bacteriophage 100%
• Infection 25%
• Clinical Trial 25%
• Side Effect 12%
• Antibiotics 12%
• Liver Function 12%
• Cell Count 12%
• Phage Therapy 12%
• Leukocyte 12%
• Treatment Duration 12%
• Device Infection 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Pseudomonas Infection 100%
• Bacteriophage 100%
• Infection 22%
• Clinical Trial 22%
• Side Effect 11%
• Antibiotics 11%
• Device Infection 11%